Saturday Nov 30
"K-V Pharmaceutical Company - Strategic SWOT Analysis Review" is now...
The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
Senate passes bill to regulate compounding pharmacies
The Senate has passed a bill - which was supported by pharmaceutical companies such as KV Pharmaceutical - that gives the Food and Drug Administration more authority to police compounding pharmacies.
KV Pharmaceutical Completes New Board With Appointment of Former Johnson & Johnson Executive
Ms. Vergis currently serves as the Executive-In-Residence at Warburg Pincus, LLC. Previously, she was the CEO of OraPharma, Inc. where she led the company's successful turnaround.
KV Pharmaceutical appoints final board member
KV Pharmaceutical has completed its first goal after emerging from bankruptcy in September: filling its new board.
KV settles with lenders in $5 million deal
KV Pharmaceutical Co. has reached a $5 million settlement with a group of senior secured lenders who had filed suit against the company.